Physician profile
Jon Robitschek
NPI 1487666525
$4,225.53
in general payments reported to CMS, 2019-2025
7 companies · $2,639 in 2025
The $2,639 reported for 2025 was more than what 92% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $272 · 2022: $69.83 · 2023: $1,120 · 2024: $125 · 2025: $2,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,152 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,000 · Consulting Fee: $1,000 · Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,152.28 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,000.00 |
| Consulting Fee | $1,000.00 |
| Food and Beverage | $731.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $3,324.59 | 2023-2025 | |
| Stryker Corporation | $253.32 | 2025 | Na, Vsp System, Vsp Cranial |
| Medical Device Business Services, INC. | $189.99 | 2024-2025 | Trumatch |
| Medtronic, INC. | $155.56 | 2021 | |
| Kls-Martin L.P. | $131.18 | 2021-2025 | |
| Genzyme Corporation | $101.06 | 2025 | |
| Biotissue Holdings INC. | $69.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Robitschek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.